Statistics for DiaMedica Therapeutics (id:5825 DMAC)
Valuation metrics
Market cap
171.47M
Enterprise value
122.45M
Trailing P/E (ttm)
-7.83
Forward P/E
-5.42
PEG ratio
-5.42
Price/Sales (ttm)
Price/Book (mrq)
2.98
Enterprise Value/Revenue
Enterprise Value/EBITDA
-5.48
Overview
Shares outstanding
42.75M
Float
26.26M
Shares short
175.55K
% Held by insiders
0.26%
% Held by institutions
0.32%
Average volume (10 days)
46.83K
Average volume (90 days)
Price summary
52-Week low
2.14
52-Week high
4.95
52-Week change
44.04%
Beta
1.46
50-Day moving average
4.30
200-Day moving average
3.36
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
November 15th, 2018
Ex-dividend date
Last split factor
2:1
Last split date
November 15th, 2018
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
June 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-23.54%
Return on equity
-35.18%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-22,350,000.00
Net income to common (ttm)
-19,902,000.00
Diluted EPS (ttm)
-0.51
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
54.06M
Total cash per share (mrq)
1.26
Total debt (mrq)
388.00K
Total Debt/Equity (mrq)
0.73
Current ratio (mrq)
1.78K%
Book value per share (mrq)
1.34
Cash flow
Cash flow statement
-19,781,000.00
Levered free cash flow (LFCF)
-11,141,000.00